Smith v. Daneshjoo, Unpublished Decision (8-23-2002)

CourtOhio Court of Appeals
DecidedAugust 23, 2002
DocketC.A. Case No. 18802 and 19088, T.C. Case No. 97-2588.
StatusUnpublished

This text of Smith v. Daneshjoo, Unpublished Decision (8-23-2002) (Smith v. Daneshjoo, Unpublished Decision (8-23-2002)) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smith v. Daneshjoo, Unpublished Decision (8-23-2002), (Ohio Ct. App. 2002).

Opinion

OPINION
Radiology Physicians, Inc. ("Radiology Physicians") appeals from a judgment entered upon a jury verdict in the Montgomery County Court of Common Pleas, which awarded $750,000 to Tara Lynn Smith and $200,000 each to her husband and two sons related to her medical malpractice claim. Radiology Physicians also appeals from an award of prejudgment interest.

In early 1995, Smith felt a lump in her right breast and went to see her gynecologist about it. Although the gynecologist was unable to feel the lump himself, he ordered a mammogram in March 1995. Dr. Josef Wenker of Radiology Physicians interpreted the mammogram and compared it to a mammogram of Smith from the prior year, concluding that the mammogram was normal and showed no signs of malignancy. Wenker recommended that Smith have another mammogram in one to two years. Smith sought further evaluation of the lump in her breast in November 1995, whereupon a malignant tumor was discovered. She later filed a malpractice claim against Radiology Physicians for Wenker's failure to diagnose her cancer in March 1995.

In addition to these undisputed facts, Smith presented the following evidence. According to Smith's experts, the tumor was about two centimeters in diameter in March 1995 and should have been apparent to Wenker when he looked at the mammogram. Smith's experts opined that the cancer probably had been in stage one or early stage two at that time and probably had not spread to her lymph nodes or had spread to only one or two. By November, the cancer was in stage three, and ten lymph nodes under Smith's arm were involved. The chances of recovery from a stage three cancer are much smaller than from a stage one cancer, and the chance of recurrence is much greater. Also, the larger size of the cancer in November and its more advanced stage necessitated a radical mastectomy and the most aggressive form of chemotherapy treatment, whereas a lumpectomy and a less toxic form of chemotherapy would probably have been sufficient if the tumor had been diagnosed in March 1995.

Oncologists and cardiologists testified that cardiomyopathy, or weakness in the heart muscle, is a recognized risk of the aggressive form of chemotherapy that Smith had received. Smith realized that she had been afflicted with this condition in September 1996, when she was admitted to the hospital with congestive heart failure. Although medications improved her heart condition somewhat, experts testified that she would never be able to return to her normal activities or to work because of the weakness of her heart, which was irreversible. They also testified that she would need to take medication for this heart condition for the rest of her life. Smith was free of cancer at the time of trial, but her experts testified that she had a very high likelihood of recurrence.

Radiology Physicians presented expert testimony that Smith's lymph nodes had probably already been involved in her cancer in March 1995 and that Smith would have received the same treatment if she had been diagnosed in March as she received in November. Experts also pointed out that some of the classic signs of malignancy on a mammogram had been absent from Smith's March 1995 films. Defense experts testified that technology might not have permitted a better diagnosis in March 1995 and that there would have been no statistical difference in Smith's odds of recurrence if the cancer had been discovered in March rather than in November. Radiology Physicians also presented expert testimony that Smith had only a ten percent chance of dying of cancer in next 20 years. Finally, the defense presented expert testimony that Smith had suffered from a preexisting heart condition, that the aggressive chemotherapy that she had been given had aggravated that condition but had not created it, and that there had been no lasting adverse effects on Smith's heart as a result of her chemotherapy.

As discussed supra, the jury returned a verdict in favor of Smith, her husband, and her children. In an interrogatory, the jury expressly found that Wenker had "fail[ed] to use `standard of care' in the reading of March 1995 mammogram and fail[ed] to recommend further evaluations of the area in question." The trial court overruled Radiology Physicians' motions for a judgment notwithstanding the verdict and for a new trial. In Case No. 18802, Radiology Physicians appeals from the judgment rendered upon the jury's verdict, raising two assignments of error.

After the trial, Smith filed a motion for prejudgment interest on the basis that Radiology Physicians had not entered into good faith settlement negotiations prior to trial. After conducting a hearing on the matter, the trial court granted the motion for prejudgment interest. In Case No. 19088, Radiology Physicians appeals from this judgment.

We will address these appeals together in this opinion, beginning with the issues raised in Case No. 18802.

"I. THE TRIAL COURT ERRED WHEN IT OVERRULED THE APPELLANT'S MOTION FOR DIRECTED VERDICT, AND APPELLANT'S MOTION FOR JUDGMENT NOTWITHSTANDING THE VERDICT OR, IN THE ALTERNATIVE, MOTION FOR A NEW TRIAL."

Radiology Physicians claims that the trial court should have directed a verdict in its favor or granted it a new trial because Smith had been "cured" of cancer at the time of trial and because the possibility of recurrence was speculative. Radiology Physicians contends that "no actual injury had, in fact, materialized" and that Smith had suffered "no loss proportionate to the jury's verdict." This argument presumes that the jury compensated Smith as if she were certain to die when, in fact, she is "cured" and may never have a recurrence. Radiology Physicians also objects to allowing the jury to rely on statistics in determining Smith's likelihood of recurrence, when Smith was not part of the studies from which the statistics were developed.

As a preliminary matter, we note that Radiology Physicians conceded at trial that there was sufficient evidence of damages related to the cardiomyopathy to go to the jury and argued only that it should have been granted a directed verdict on the issue of future damages from cancer because Smith had been "cured" of that condition. The trial court concluded that there was sufficient evidence of damages from cancer to submit the matter to the jury. We note that Radiology Physicians did not request jury interrogatories that would have differentiated between damages related to Smith's heart condition and damages related to cancer. Thus, we do not know whether the jury awarded any damages based on the risk of a recurrence of cancer and do not know whether Radiology Physicians was harmed by the alleged error.

In our view, however, the trial court did not err in concluding that there was sufficient evidence to submit the issue of damages from cancer to the jury. Aside from the issue of future damages, Smith had already suffered significant damages related to the treatment of her cancer at the time of trial, and there was evidence from which the jury could have concluded that these damages were caused by the delay in her diagnosis. Smith presented evidence that she had been required to endure a more toxic chemotherapy treatment than would have been necessary if she had been diagnosed at the time of her March 1995 mammogram and that she had been required to have a mastectomy rather than a lumpectomy because of this delay. These damages were properly submitted to the jury along with damages from the cardiomyopathy, which Smith associated with the chemotherapy drugs.

The first assignment of error is overruled.

"II. THE TRIAL COURT ERRED TO THE PREJUDICE OF THE APPELLANT WHEN IT ADMITTED, OVER APPELLANT'S OBJECTION, INADMISSIBLE, SPECULATIVE HEARSAY EXPERT TESTIMONY."

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Courtney v. Taylor
708 N.E.2d 1053 (Ohio Court of Appeals, 1998)
Huffman v. Hair Surgeon, Inc.
482 N.E.2d 1248 (Ohio Supreme Court, 1985)
Kalain v. Smith
495 N.E.2d 572 (Ohio Supreme Court, 1986)
Stinson v. England
633 N.E.2d 532 (Ohio Supreme Court, 1994)
Moskovitz v. Mt. Sinai Medical Center
635 N.E.2d 331 (Ohio Supreme Court, 1994)
Stinson v. England
1994 Ohio 35 (Ohio Supreme Court, 1994)
Wightman v. Consolidated Rail Corp.
1999 Ohio 119 (Ohio Supreme Court, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
Smith v. Daneshjoo, Unpublished Decision (8-23-2002), Counsel Stack Legal Research, https://law.counselstack.com/opinion/smith-v-daneshjoo-unpublished-decision-8-23-2002-ohioctapp-2002.